BioSpace News Archive

Medicenna Therapeutics Corp. (“Medicenna” or “the Company”) (TSX: MDNA, OTCQB: MDNAF), a clinical stage immunotherapy company developing first-in-class Superkines and Empowered Cytokines, presented new pre-clinical data on its IL-2 Superkine program, MDNA109.

Cancer Prevention Pharmaceuticals, Inc. (CPP) recently reported results from its pivotal Phase 3 trial of CPP-1X/sul for adults with familial adenomatous polyposis (FAP) at the Digestive Disease Week annual conference in San Diego.

Syntrix Pharmaceuticals today announced that it has dosed the first patient in its Phase 1/2 clinical trial that will combine SX-682 with KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy. SX-682 is an oral dual inhibitor of CXCR1 and CXCR2 (CXCR1/2) being developed for the treatment of cancer.

Data-driven industry framework is key to measuring healthcare impact and generating strong returns

On November 15th, 2019, expectant parents and healthcare professionals are invited to participate in World Cord Blood Day events being held online and around the globe to celebrate over 30 years of life-saving cord blood transplants and learn about innovative research in the field.

Company initiates program leveraging SPI-1 platform to develop selling skills

The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) is collaborating with AstraZeneca, a global, science-led biopharmaceutical company, to further quality in cancer care for people with advanced ovarian cancer.

Youth against AIDS, an international non-profit organization based in Germany that promotes sexual health worldwide and provides sexual education in schools and youth facilities all over the world, announced the agreement of a global partnership with LifeStyles Healthcare, the world’s leading sexual wellness company.

Today eMDs, a leading provider of innovative electronic health record (EHR), practice management (PM) and revenue cycle management (RCM) solutions for medical practices, announced that Bluestone Physician Services selected it as their new EHR/PM solution

Syqe Medical, a leading pharma-tech company, today announced the launch of the world’s first pharmaceutical-grade metered-dose cannabis inhaler in Israel, empowering physicians to prescribe precise dosages meeting pharmaceutical standards